Literature DB >> 23013896

Determination of seven phenolic compounds in Rhizoma Sparganii by RP-HPLC.

Xinsheng Wang1, Qi-nan Wu, Yanfang Wu, Chengying Wu, Wei Yue, Qiaoli Liang.   

Abstract

A reversed-phase high-performance liquid chromatographic method was developed for the simultaneous quantification of seven phenolic compounds from Rhizoma Sparganii. The samples were separated on a Waters SunFire C18 column with a temperature of 30°C. Gradient elution was applied, using 0.8% acetic acid (solvent A) and methanol (solvent B) with a flow rate of 1.0 mL/min, and detection wavelength was 280 nm. The validation of the method included linearity, precision, repeatability, stability and recovery. The calibration curves showed good linear regression (R(2) > 0.9996) within the test range. The developed method indicated good precision and accuracy, with the overall intra-day and inter-day variation at less than 3%. The range of recoveries for the seven analytes was 95.34-100.06% with relative standard deviation < 3.08 %. The established method was successfully applied for the determination of seven phenolic compounds in 12 batches of Rhizoma Sparganii. The study may be useful in the quality evaluation of Rhizoma Sparganii, and can provide technical support for pharmacological and clinical research of related drugs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23013896     DOI: 10.1093/chromsci/bms150

Source DB:  PubMed          Journal:  J Chromatogr Sci        ISSN: 0021-9665            Impact factor:   1.618


  2 in total

1.  Discovery and identification of quality markers of Sparganii Rhizoma based on zebrafish thrombosis model.

Authors:  Nan Xu; Rong Sun; Yin-Ping Shi; Li-Wen Han; Hai-Yan Shi
Journal:  Chin Herb Med       Date:  2021-04-27

2.  Effects of Sparganii Rhizoma on Osteoclast Formation and Osteoblast Differentiation and on an OVX-Induced Bone Loss Model.

Authors:  Sungyub Lee; Minsun Kim; Sooyeon Hong; Eom Ji Kim; Jae-Hyun Kim; Youngjoo Sohn; Hyuk-Sang Jung
Journal:  Front Pharmacol       Date:  2022-01-04       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.